We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Optimizing Application And Support Of Immunization Information Systems (OASIS) (OASIS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02010372
Recruitment Status : Completed
First Posted : December 12, 2013
Last Update Posted : February 25, 2016
Sponsor:
Collaborator:
Information provided by (Responsible Party):

Study Description
Brief Summary:
The overall purpose of this study is to evaluate the use of features of the New York State Immunization Information System (NYSIIS) by various types of primary care practices and determine how best to promote the use of IIS features and functionality. The primary goal is to promote the use of NYSIIS for immunization quality improvement (QI) in the practice setting. Customized training sessions will be conducted by study staff to educate practices on NYSIIS' enhanced features.

Condition or disease Intervention/treatment
Increase in Use of Immunization Registry Increase in HPV Vaccination Rate Other: Reminder Recall Report Other: Audit-Feedback/Immunization Forecasting Reports

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 31 participants
Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Optimizing the Practical Application of Immunization Information System Use in Primary Care Practices
Study Start Date : December 2013
Primary Completion Date : May 2015
Study Completion Date : July 2015
Arms and Interventions

Arm Intervention/treatment
Experimental: Reminder Recall Reports
Training in how to use reminder-recall reports in the Immunization registry will be given to administrators who will then be asked to regularly run these reports for a period of one year.
Other: Reminder Recall Report
Practices (administrators) that are randomized to this intervention will receive training in how to run reminder recall reports for patients due to receive any dose of HPV vaccine. After the training has been completed, administrators will be asked to continue running regularly scheduled reports over the course of one year. A tracking log will be sent regularly to the research team.
Experimental: Audit-Feedback/Immunization Forecasting Reports
Training in how to use audit-feedback/immunization forecasting reports in the Immunization registry will be given to administrators who will then be asked to regularly run these reports for a period of one year.
Other: Audit-Feedback/Immunization Forecasting Reports
Practices (administrators) that are randomized to this intervention will receive training in how to run audit-feedback/immunization forecasting reports for patients due to receive any dose of HPV vaccine and to determine the % of patients in their practice who have received at least one dose of HPV vaccine within the study period. After the training has been completed, administrators will be asked to continue running regularly scheduled reports over the course of one year. A tracking log will be sent regularly to the research team.
No Intervention: Control
No intervention will be administered to this group.


Outcome Measures

Primary Outcome Measures :
  1. NYSIIS report usage [ Time Frame: One Year ]
    Practice NYSIIS administrators will monitor the number of reports their practice generates throughout the 12 month post-training period. These measures for control and intervention practices will be compared in bivariate and multivariate analysis.


Secondary Outcome Measures :
  1. HPV Vaccination Rate [ Time Frame: One Year ]
    HPV Vaccination rates will be measured to determine the change in the practice's immunization levels (for the pre-determined immunization QI goal) over the 12-month period following their initial training. Statistical comparisons of control and intervention practice will be performed using bivariate analyses, while multivariate analyses will be used to account for the effects of practice characteristics.


Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • NYSIIS administrator at a participating practice

Exclusion Criteria:

  • Practices already utilizing/running reports used in the intervention
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02010372


Locations
United States, New York
University of Rochester
Rochester, New York, United States, 14642
Sponsors and Collaborators
University of Rochester
Centers for Disease Control and Prevention
Investigators
Principal Investigator: Stanley J Schaffer, MD, MPH University of Rochester
More Information

Responsible Party: Stanley J Schaffer, MD, Principal Investigator, University of Rochester
ClinicalTrials.gov Identifier: NCT02010372     History of Changes
Other Study ID Numbers: 5U01IP000502 ( U.S. NIH Grant/Contract )
First Posted: December 12, 2013    Key Record Dates
Last Update Posted: February 25, 2016
Last Verified: February 2016

Keywords provided by Stanley J Schaffer, MD, University of Rochester:
Immunization Registry
Human Papillomavirus

Additional relevant MeSH terms:
Vaccines
Immunologic Factors
Physiological Effects of Drugs